TOKYO–(BUSINESS WIRE)–The Japan natto cooperative society federation (Arakawa-ku, Tokyo; Chairman: Yoshihiro Noro) has launched the Chinese version of its new website, “Natto Power — Japanese Fermented Food Natto, the key to Better Living –” to promote the power of natto, a traditional Japanese food that has supported Japanese people’s health, to the world. • “Natto … [Read more…]

TOKYO–(BUSINESS WIRE)–The Japan natto cooperative society federation (Arakawa-ku, Tokyo; Chairman: Yoshihiro Noro) has launched its new website, “Natto Power — Japanese Fermented Food Natto, the key to Better Living –” to promote the power of natto, a traditional Japanese food that has supported Japanese people’s health, to the world. • “Natto Power” official English website … [Read more…]

MEXICO CITY–(BUSINESS WIRE)–#Mexico–Activists and public health experts in Mexico demand that officials of the Mexican Ministry of Health (SSA) and the Federal Commission for the Protection against Sanitary Risks (COFEPRIS) authorize the use of monkeypox (mpox) vaccines in the country. “Despite the fact that mpox was declared a Public Health Emergency of International Concern by … [Read more…]

SAN MATEO, Calif.–(BUSINESS WIRE)–Model N, Inc. (NYSE: MODN), a leading provider of cloud revenue management solutions for life sciences and high tech companies, announced today that it intends to offer, subject to market conditions and other factors, $220.0 million aggregate principal amount of convertible senior notes due 2028 in a private placement to persons reasonably … [Read more…]

MISSISSAUGA, Ontario–(BUSINESS WIRE)–Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare (TSX:MRV; OTCQX:MRVFF) (“Miravo” or the “Company”) is pleased to announce that, at today’s special meeting of shareholders (the “Meeting”), its shareholders (“Shareholders”) voted in favour of a special resolution to approve the previously announced plan of arrangement (the “Arrangement”) pursuant to which, among other things, Searchlight Pharma … [Read more…]

2022 was a year of transformation and change: reported $412.5 million in total revenue for the year ended December 31, 2022; reported net income of $124.3 million ($1.90 per fully diluted share) for 2022 compared to net loss of $211.8 million in 2021; reported $492.2 million in cash resources as of December 31, 2022, with … [Read more…]

EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–Agiliti Inc. (NYSE: AGTI) (“Agiliti”), a nationwide provider of healthcare technology management and service solutions to the United States healthcare industry, today announced its financial results for the fourth quarter and year ended December 31, 2022, and provided its financial outlook for 2023. Fourth Quarter 2022 Highlights Revenue of $282 million, a … [Read more…]

ANN ARBOR, Mich.–(BUSINESS WIRE)–$NDRA #NALFD—ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that the company will report financial results for the three months and year ended December 31, 2022 on Tuesday, March 14, 2023 after the close of trading on the U.S. financial markets. Management will … [Read more…]

EndeavorRxⓇ prescriptions increased 37% in Q4 2022 over Q3 2022 and 166% in FY 2022 over FY 2021; initial sales force gaining traction and Company is expanding to new U.S. territories Strong clinical data in adolescents with ADHD supports potential for EndeavorRx label expansion; regulatory submission to FDA expected in 2023 Company reaffirms FY 2023 … [Read more…]

ZTALMY® U.S. net product revenue of $2.3 million for the fourth quarter of 2022 and $2.9 million for the fiscal year ended December 31, 2022 Company expects ZTALMY U.S. net product revenues of between $15 million and $17 million for the fiscal year ending December 31, 2023 Second generation oral formulation development continues to advance … [Read more…]